Page last updated: 2024-10-30

edaravone and Endomyocardial Fibrosis

edaravone has been researched along with Endomyocardial Fibrosis in 1 studies

Endomyocardial Fibrosis: A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).

Research Excerpts

ExcerptRelevanceReference
"Edaravone-treated DCM rats showed better cardiac function compared with those of the vehicle-treated rats."1.38Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy. ( Arozal, W; Arumugam, S; Giridharan, VV; Harima, M; Kodama, M; Nagata, M; Nakamura, T; Palaniyandi, SS; Sari, FR; Soetikno, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arumugam, S1
Thandavarayan, RA1
Veeraveedu, PT1
Nakamura, T1
Arozal, W1
Sari, FR1
Giridharan, VV1
Soetikno, V1
Palaniyandi, SS1
Harima, M1
Suzuki, K1
Nagata, M1
Kodama, M1
Watanabe, K1

Other Studies

1 other study available for edaravone and Endomyocardial Fibrosis

ArticleYear
Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy.
    Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:9

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antipyrine; Apoptosis; Autoimmune Di

2012